In vivo stimulation of I kappa B phosphorylation is not sufficient to activate NF-kappa B - PubMed (original) (raw)
In vivo stimulation of I kappa B phosphorylation is not sufficient to activate NF-kappa B
I Alkalay et al. Mol Cell Biol. 1995 Mar.
Abstract
NF-kappa B is a major inducible transcription factor in many immune and inflammatory reactions. Its activation involves the dissociation of the inhibitory subunit I kappa B from cytoplasmic NF-kappa B/Rel complexes, following which the Rel proteins are translocated to the nucleus, where they bind to DNA and activate transcription. Phosphorylation of I kappa B in cell-free experiments results in its inactivation and release from the Rel complex, but in vivo NF-kappa B activation is associated with I kappa B degradation. In vivo phosphorylation of I kappa B alpha was demonstrated in several recent studies, but its role is unknown. Our study shows that the T-cell activation results in rapid phosphorylation of I kappa B alpha and that this event is a physiological one, dependent on appropriate lymphocyte costimulation. Inducible I kappa B alpha phosphorylation was abolished by several distinct NF-kappa B blocking reagents, suggesting that it plays an essential role in the activation process. However, the in vivo induction of I kappa B alpha phosphorylation did not cause the inhibitory subunit to dissociate from the Rel complex. We identified several protease inhibitors which allow phosphorylation of I kappa B alpha but prevent its degradation upon cell stimulation, presumably through inhibition of the cytoplasmic proteasome. In the presence of these inhibitors, phosphorylated I kappa B alpha remained bound to the Rel complex in the cytoplasm for an extended period of time, whereas NF-kappa B activation was abolished. It appears that activation of NF-kappa B requires degradation of I kappa B alpha while it is a part of the Rel cytoplasmic complex, with inducible phosphorylation of the inhibitory subunit influencing the rate of degradation.
Similar articles
- Phosphorylation of I kappa B alpha precedes but is not sufficient for its dissociation from NF-kappa B.
DiDonato JA, Mercurio F, Karin M. DiDonato JA, et al. Mol Cell Biol. 1995 Mar;15(3):1302-11. doi: 10.1128/MCB.15.3.1302. Mol Cell Biol. 1995. PMID: 7862124 Free PMC article. - Activation of NF-kappa B/Rel by Tax involves degradation of I kappa B alpha and is blocked by a proteasome inhibitor.
Maggirwar SB, Harhaj E, Sun SC. Maggirwar SB, et al. Oncogene. 1995 Sep 7;11(5):993-8. Oncogene. 1995. PMID: 7675460 - Autoregulation of the NF-kappa B transactivator RelA (p65) by multiple cytoplasmic inhibitors containing ankyrin motifs.
Sun SC, Ganchi PA, Béraud C, Ballard DW, Greene WC. Sun SC, et al. Proc Natl Acad Sci U S A. 1994 Feb 15;91(4):1346-50. doi: 10.1073/pnas.91.4.1346. Proc Natl Acad Sci U S A. 1994. PMID: 8108414 Free PMC article. - Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.
Karin M, Ben-Neriah Y. Karin M, et al. Annu Rev Immunol. 2000;18:621-63. doi: 10.1146/annurev.immunol.18.1.621. Annu Rev Immunol. 2000. PMID: 10837071 Review. - [The Rel/NF-kappa-B transcription factors: complex role in cell regulation].
Bottex-Gauthier C, Pollet S, Favier A, Vidal DR. Bottex-Gauthier C, et al. Pathol Biol (Paris). 2002 Apr;50(3):204-11. doi: 10.1016/s0369-8114(02)00289-4. Pathol Biol (Paris). 2002. PMID: 11980335 Review. French.
Cited by
- I kappaB alpha-independent downregulation of NF-kappaB activity by glucocorticoid receptor.
Heck S, Bender K, Kullmann M, Göttlicher M, Herrlich P, Cato AC. Heck S, et al. EMBO J. 1997 Aug 1;16(15):4698-707. doi: 10.1093/emboj/16.15.4698. EMBO J. 1997. PMID: 9303314 Free PMC article. - Inhibition of bovine endothelial cell activation in vitro by regulated expression of a transdominant inhibitor of NF-kappa B.
Anrather J, Csizmadia V, Brostjan C, Soares MP, Bach FH, Winkler H. Anrather J, et al. J Clin Invest. 1997 Feb 15;99(4):763-72. doi: 10.1172/JCI119222. J Clin Invest. 1997. PMID: 9045881 Free PMC article. - Liver kinase B1 is required for thromboxane receptor-dependent nuclear factor-κB activation and inflammatory responses.
He J, Zhou Y, Xing J, Wang Q, Zhu H, Zhu Y, Zou MH. He J, et al. Arterioscler Thromb Vasc Biol. 2013 Jun;33(6):1297-305. doi: 10.1161/ATVBAHA.113.301296. Epub 2013 Mar 28. Arterioscler Thromb Vasc Biol. 2013. PMID: 23539217 Free PMC article. - Chronic human immunodeficiency virus type 1 infection of myeloid cells disrupts the autoregulatory control of the NF-kappaB/Rel pathway via enhanced IkappaBalpha degradation.
DeLuca C, Roulston A, Koromilas A, Wainberg MA, Hiscott J. DeLuca C, et al. J Virol. 1996 Aug;70(8):5183-93. doi: 10.1128/JVI.70.8.5183-5193.1996. J Virol. 1996. PMID: 8764027 Free PMC article. - IkappaB kinase (IKK)-associated protein 1, a common component of the heterogeneous IKK complex.
Mercurio F, Murray BW, Shevchenko A, Bennett BL, Young DB, Li JW, Pascual G, Motiwala A, Zhu H, Mann M, Manning AM. Mercurio F, et al. Mol Cell Biol. 1999 Feb;19(2):1526-38. doi: 10.1128/MCB.19.2.1526. Mol Cell Biol. 1999. PMID: 9891086 Free PMC article.
References
- Science. 1989 Apr 28;244(4903):457-60 - PubMed
- Biochemistry. 1992 Oct 6;31(39):9421-8 - PubMed
- Mol Cell Biol. 1989 Jun;9(6):2424-30 - PubMed
- Trends Neurosci. 1989 Nov;12(11):438-44 - PubMed
- Biochem J. 1989 Sep 15;262(3):693-706 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources